Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells

Documenti analoghi

• PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization
  di: Rekoske, Brian T., et al.
  Pubblicazione: (2015)
• DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses()
  di: Smith, Heath A., et al.
  Pubblicazione: (2014)
• Vaccines Targeting the Cancer Testis Antigen SSX-2 Elicit HLA-A2 Epitope-Specific Cytolytic T Cells
  di: Smith, Heath A., et al.
  Pubblicazione: (2011)
• Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses
  di: Rekoske, Brian T., et al.
  Pubblicazione: (2016)
• The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
  di: Smith, Heath A., et al.
  Pubblicazione: (2010)